DIA's Annual Canadian Meeting: New Reality / New Frontiers

Patient support programs have been around in one form or another for many years. However, with a significant number of molecules going off patent and the complexity of some of the new medications be they drug, device or a combination drug/device, manufacturers are turning to these programs with increasing attention. This session will explore what drivers prompt new programs, their format and their deliverables. We will hear, what are best practices, what factors need to be considered and monitored and even some of the pitfalls that can be avoided. Finally, we will also hear the patients’ perspective on whether these programs are value added – or not.